Prophylaxis and Conservative Management of Acute Renal Failure in the ICU

Abstract

Get full access to this article

View all access options for this article.

References

Badr

K.F.

. Novel mediators of sepsis-associated renal failure. Sem Nephrol 1994; 14: 3–7.

Baldwin

, Henderson

, Hickman

. Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery. Ann Intern Med 1994; 120: 744–7.

Bodenham

A.R.

, Park

G.R.

. Dopexamine hydrochloride, a novel drug with renal vasodilator properties: two case studies. Intensive Care Med 1988; 14: 663–5.

Duke

G.J.

, Bersten

A.D.

. Dopamine and renal salvage in the critically ill patient. Anaesthetic Intensive Care 1992; 20: 277–302.

Epstein

. Calcium antagonists and the kidney. Furthermore therapeutic perspectives. Am J Kidney Dis 1993; 21(suppl 3): 16–25.

Fischereder

, Trick

, Nath

K.A.

. Therapeutic strategies in the prevention of acute renal failure. Sem Nephrol 1994; 14: 41–52.

Gray

P.A.

, Bodenham

A.R.

, Park

G.R.

. A comparison of dopexamine and dopamine to prevent renal impairment in patients undergoing orthoptic liver transplantation. Anaesthesia 1991; 46: 638–41.

Greene

E.L.

, Paller

M.S.

. Oxygen free radicals in acute renal failure. Mineral and Electrolyte Metabolism 1991; 17: 124–32.

Grino

J.M.

BN52021: Platelet activating factor antagonist for preventing post-transplant renal failure. A double blind, randomised study.

Ann Intern Med 1994; 121: 345–7.

10.

Lake

E.W.

, Humes

H.D.

. Acute renal failure. Directed therapy to enhance renal tubular regeneration. Sem Nephrol 1994; 4: 83–97.

11.

Lichtwark-Aschoff

, Zeravik

, Pfeiffer

U.J.

. Intrathoracic blood volume accurately reflects circulatory volume status in critically ill patients with mechanical ventilation. Intensive Care Med 1992; 18: 142–7.

12.

Lindner

. Synergism of dopamine and furosemide in diuretic resistant oliguric renal failure. Nephron 1983; 33: 121–6.

13.

Magrini

, Foulds

, Roberts

, Macchi

, Mondadori

, Zanchetti

. Human renovascular effects of dopexamine hydrochloride. A novel agonist of peripheral dopamine and beta₂-adreno-receptors. Eur J Clin Pharmacol 1987; 32: 1–4.

14.

Neumayer

H.H.

, Junge

, Kufner

, Wenning

. Prevention of radiocontrast media-induced nephrotoxicity by the calcium channel blocker nitrendipine. A prospective randomised trial. Nephrol Dialys Transplant 1989; 4: 1030–6.

15.

Pawlik

, Mailman

, Shanbour

L.L.

, Jacobson

E.D.

. Dopamine effects on intestinal circulation. Am Heart J 1976; 91: 325–31.

16.

Pollock

D.M.

, Opgenorth

T.J.

. Artrial natriuretic peptides in the treatment of acute renal failure. Renal Failure 1993; 15: 439–49.

17.

Russo

, Testa

, Delia Volpe

, Sansone

. Randomized prospective study on renal effects of two different contrast media in humans. Protective role of calcium channel blocker. Nephron 1990; 55: 254–7.

18.

Szerlip

H.M.

. Renal-dose dopamine: fact and fiction. Ann Intern Med 1991; 115: 153–4.

19.

Thompson

B.T.

, Cockrill

B.A.

. Renal dose dopamine: a siren song? Lancet 1994; 344: 7–8.

20.

Wetzels

J.F.M.

, Burke

T.J.

, Schrier

R.W.

. Calcium channel blockers. Protective effects in ischaemic acute renal failure. Renal Failure 1992; 14: 327–32.